220 related articles for article (PubMed ID: 31980695)
1. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.
Deh K; Zaman M; Vedvyas Y; Liu Z; Gillen KM; O' Malley P; Bedretdinova D; Nguyen T; Lee R; Spincemaille P; Kim J; Wang Y; Jin MM
Sci Rep; 2020 Jan; 10(1):1171. PubMed ID: 31980695
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility weighted imaging and quantitative susceptibility mapping of the cerebral vasculature using ferumoxytol.
Liu S; Brisset JC; Hu J; Haacke EM; Ge Y
J Magn Reson Imaging; 2018 Mar; 47(3):621-633. PubMed ID: 28731570
[TBL] [Abstract][Full Text] [Related]
3. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
[TBL] [Abstract][Full Text] [Related]
4. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.
McConnell HL; Schwartz DL; Richardson BE; Woltjer RL; Muldoon LL; Neuwelt EA
Nanomedicine; 2016 Aug; 12(6):1535-42. PubMed ID: 27071335
[TBL] [Abstract][Full Text] [Related]
5. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
[TBL] [Abstract][Full Text] [Related]
6. Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.
Sterenczak KA; Meier M; Glage S; Meyer M; Willenbrock S; Wefstaedt P; Dorsch M; Bullerdiek J; Murua Escobar H; Hedrich H; Nolte I
BMC Cancer; 2012 Jul; 12():284. PubMed ID: 22784304
[TBL] [Abstract][Full Text] [Related]
8. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
9. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
10. Measurements of cerebral blood volume using quantitative susceptibility mapping, R
Rivera-Rivera LA; Schubert T; Johnson KM
NMR Biomed; 2019 Dec; 32(12):e4175. PubMed ID: 31482602
[TBL] [Abstract][Full Text] [Related]
11. Magnetic nanoparticle biodistribution following intratumoral administration.
Giustini AJ; Ivkov R; Hoopes PJ
Nanotechnology; 2011 Aug; 22(34):345101. PubMed ID: 21795772
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
Ma HL; Xu YF; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2008 Apr; 354(1-2):217-26. PubMed ID: 18191350
[TBL] [Abstract][Full Text] [Related]
14. Ultrasmall Superparamagnetic Iron Oxide Imaging Identifies Tissue and Nerve Inflammation in Pain Conditions.
Shen S; Ding W; Ahmed S; Hu R; Opalacz A; Roth S; You Z; Wotjkiewicz GR; Lim G; Chen L; Mao J; Chen JW; Zhang Y
Pain Med; 2018 Apr; 19(4):686-692. PubMed ID: 29177411
[TBL] [Abstract][Full Text] [Related]
15. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.
Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG
AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664
[TBL] [Abstract][Full Text] [Related]
16. Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles.
Elias A; Tsourkas A
Hematology Am Soc Hematol Educ Program; 2009; ():720-6. PubMed ID: 20008258
[TBL] [Abstract][Full Text] [Related]
17. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
Du Y; Liu X; Liang Q; Liang XJ; Tian J
Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
[TBL] [Abstract][Full Text] [Related]
18. R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.
Kuhlpeter R; Dahnke H; Matuszewski L; Persigehl T; von Wallbrunn A; Allkemper T; Heindel WL; Schaeffter T; Bremer C
Radiology; 2007 Nov; 245(2):449-57. PubMed ID: 17848680
[TBL] [Abstract][Full Text] [Related]
19. Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment: tracers, hardware, and future medical applications.
Chandrasekharan P; Tay ZW; Hensley D; Zhou XY; Fung BK; Colson C; Lu Y; Fellows BD; Huynh Q; Saayujya C; Yu E; Orendorff R; Zheng B; Goodwill P; Rinaldi C; Conolly S
Theranostics; 2020; 10(7):2965-2981. PubMed ID: 32194849
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
